Eye Itch Releif
- Product NDC
- 11822-5533
- 11-digit product format
- 118225533
- Labeler code
- 11822
- Product ID
- 11822-5533_1ddd5a87-3863-532b-e063-6394a90ab8bf
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ketotifen Fumarate
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Rite Aid Corporation
- Application
- NDA021996
- Marketing category
- NDA
- Marketing start
- 2022-04-01
- Substance
- KETOTIFEN FUMARATE
- Active strength
- .25 mg/mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eye Itch Releif
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| KETOTIFEN FUMARATE | .25 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | HBD503WORO |
| Rxcui | 311237 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11822-5533-1 | Eye Itch Releif | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | | 3 |
| 11822-5533-1 | Eye Itch Releif | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11822-5533 | EYE ITCH RELEIF (KETOTIFEN FUMARATE) SOLUTION/ DROPS [RITE AID CORPORATION] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240724_6a7be1e9-27ff-44d8-85ed-fc1b0017180e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11822-5533-1 | 11822553301 | 1 BOTTLE, DROPPER in 1 CARTON (11822-5533-1) / 10 mL in 1 BOTTLE, DROPPER | 2022-04-01 | 0000-00-00 | No | No | Current |